The ERRα/PGC1α complex has been reported to regulate mitochondrial biogenesis [65], and XCT790 disrupted this complex interaction with growth-inhibitory therapeutic effects in breast cancer [12]. This evidence concerns the gene ESRRA and breast carcinoma.